Utama › Sklerosis Pelbagai › Alabama
Kajian klinikal Sklerosis Pelbagai di Alabama
8 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi di Alabama.
Bandar di Alabama
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Alabama Neurology Associates, Birmingham
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06782490Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
- University of Alabama at Birmingham, Birmingham
Mengambil peserta
Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07475377A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Birmingham
- TG Therapeutics Investigational Trial Site, Cullman
- TG Therapeutics Investigational Trial Site, Huntsville
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- North Central Neurology Associates- Site Number : 8401100, Cullman
- Alabama Neurology Associates- Site Number : 8400115, Homewood
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Alabama Neurology Associates PC, Birmingham
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07225504Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
- University of Alabama at Birmingham Medical Center, Birmingham
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 2 Jun 2026 · NCT03759522Care in Multiple Sclerosis (MS)
- University of Alabama at Birmingham, Birmingham
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT07011914Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.